Anavex Life Sciences Corp (AVXL)

[nidan7500]

powerwqalker : isn't the most significant part of today's PR is that Anavex is stating that the P2b/3 shows benefits that reduce the impact of dementia. If this weren't true, lawsuits will fly when results are disclosed ... no lawyer worth his/her salt would allow a client to state this, unless it is TRUE!! Clayton Parker would not let this out unless it is TRUE!!

. Agree w/your point.

AVXL also has a powerful portfolio of RWD-RWE facts which will ultimately support the MOA for S1R (read systemic) CNS rebalancing-recovery. AVXL has not gone w/the STAT SPEAK trial model driven by FDA. We see that line of reasoning as one that provides the FDA w/a place to hide while RWD-RWE facts are more difficult-risky to obtain and present, they are certainly not a shell game, like FDA STAT-SPEAK has been . This is all starting to paint the FDA into a corner of their own design. Now maybe we can move on and rely on solid thinking/engineering and Bio-chem science reproducible facts as our clinical-trials evidence.